-
1
-
-
0028783948
-
Tissue plasminogen activator for acute ischemic stroke
-
The National Institute of Neurological Disorders and Stroke rt-PA Study Group.
-
The National Institute of Neurological Disorders and Stroke rt-PA Study Group. Tissue plasminogen activator for acute ischemic stroke. N Eng J Med. 1995;333:1581-1588.
-
(1995)
N Eng J Med.
, vol.333
, pp. 1581-1588
-
-
-
2
-
-
52649165720
-
Thrombolysis with alteplase in 3 to 4.5 hours after ischemic stroke
-
Hacke W, Kaste M, Bluhmki E, Brozman M, Davalos A, Guidetti D, et al. Thrombolysis with alteplase in 3 to 4.5 hours after ischemic stroke. N Eng J Med. 2008;359:1317-1329.
-
(2008)
N Eng J Med.
, vol.359
, pp. 1317-1329
-
-
Hacke, W.1
Kaste, M.2
Bluhmki, E.3
Brozman, M.4
Davalos, A.5
Guidetti, D.6
-
3
-
-
84862625338
-
The benefts and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke: A randomized controlled trial
-
The IST-3 Collaborative Group.
-
The IST-3 Collaborative Group. The benefts and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke: a randomized controlled trial. Lancet. 2012;379:2352-2363.
-
(2012)
Lancet.
, vol.379
, pp. 2352-2363
-
-
-
4
-
-
84862629039
-
Recombinant tissue plasminogen activator for acute isch-aemic stroke: An updated systematic review and meta-analysis
-
Wardlaw JM, Murray V, Berge E, del Zoppo G, Sandercock P, Lindley RL, et al. Recombinant tissue plasminogen activator for acute isch-aemic stroke: an updated systematic review and meta-analysis. Lancet. 2012;379:2364-2372.
-
(2012)
Lancet.
, vol.379
, pp. 2364-2372
-
-
Wardlaw, J.M.1
Murray, V.2
Berge, E.3
Del Zoppo, G.4
Sandercock, P.5
Lindley, R.L.6
-
6
-
-
77649126524
-
Heart disease and stroke statistics-2010 update: A report from the American Heart Association
-
Lloyd-Jones D, Adams RJ, Brown TM, Carnethon M, Dai S, De Simone G, et al. Heart disease and stroke statistics-2010 update: A report from the American Heart Association. Circulation. 2010;121:e46-e215.
-
(2010)
Circulation.
, vol.121
-
-
Lloyd-Jones, D.1
Adams, R.J.2
Brown, T.M.3
Carnethon, M.4
Dai, S.5
De Simone, G.6
-
7
-
-
12844262772
-
Ethnic disparities in stroke: Epidemiology, acute care, and postacute outcomes
-
Stansbury JP, Jia H, Williams LS, Vogel WB, Duncan PW. Ethnic disparities in stroke: epidemiology, acute care, and postacute outcomes. Stroke. 2005;36:374-386.
-
(2005)
Stroke.
, vol.36
, pp. 374-386
-
-
Stansbury, J.P.1
Jia, H.2
Williams, L.S.3
Vogel, W.B.4
Duncan, P.W.5
-
8
-
-
0032952809
-
Stroke incidence and survival among middle-aged adults: 9-year follow-up of the Atherosclerosis Risk in Communities (ARIC) cohort
-
Rosamond WD, Folsom AR, Chambless LE, Wang CH, McGovern PG, Howard G, et al. Stroke incidence and survival among middle-aged adults: 9-year follow-up of the Atherosclerosis Risk in Communities (ARIC) cohort. Stroke. 1999;30:736-743.
-
(1999)
Stroke.
, vol.30
, pp. 736-743
-
-
Rosamond, W.D.1
Folsom, A.R.2
Chambless, L.E.3
Wang, C.H.4
McGovern, P.G.5
Howard, G.6
-
9
-
-
0035460848
-
Ethnic disparities in stroke: The scope of the problem
-
Howard G, Howard VJ; REasons for Geographic And Racial Differences in Stroke (REGARDS) Investigators. Ethnic disparities in stroke: the scope of the problem. Ethn Dis. 2001;11:761-768.
-
(2001)
Ethn Dis.
, vol.11
, pp. 761-768
-
-
Howard, G.1
Howard, V.J.2
-
11
-
-
77950879402
-
Race/ethnicity, quality of care, and outcomes in ischemic stroke
-
Schwamm LH, Reeves MJ, Pan W, Smith EE, Frankel MR, Olson D, et al. Race/ethnicity, quality of care, and outcomes in ischemic stroke. Circulation. 2010;121:1492-1501.
-
(2010)
Circulation.
, vol.121
, pp. 1492-1501
-
-
Schwamm, L.H.1
Reeves, M.J.2
Pan, W.3
Smith, E.E.4
Frankel, M.R.5
Olson, D.6
-
12
-
-
33751004405
-
African American women have poor long-term survival following ischemic stroke
-
Qureshi AI, Suri MF, Zhou J, Divani AA. African American women have poor long-term survival following ischemic stroke. Neurology. 2006;67:1623-1629.
-
(2006)
Neurology.
, vol.67
, pp. 1623-1629
-
-
Qureshi, A.I.1
Suri, M.F.2
Zhou, J.3
Divani, A.A.4
-
13
-
-
77956713424
-
Trends in thrombolytic use for isch-emic stroke in the United States
-
Fang MC, Cutler DM, Rosen AB. Trends in thrombolytic use for isch-emic stroke in the United States. J Hosp Med. 2010;5:406-409.
-
(2010)
J Hosp Med.
, vol.5
, pp. 406-409
-
-
Fang, M.C.1
Cutler, D.M.2
Rosen, A.B.3
-
14
-
-
0343990052
-
Subgroup analysis of the NINDS t-PA Stroke Trial. The NINDS tPA Study Group
-
Generalized effcacy of t-PA for acute stroke.
-
Generalized effcacy of t-PA for acute stroke. Subgroup analysis of the NINDS t-PA Stroke Trial. The NINDS tPA Study Group. Stroke. 1997;28:2119-2125.
-
(1997)
Stroke.
, vol.28
, pp. 2119-2125
-
-
-
15
-
-
4944222683
-
Findings from the reanalysis of the NINDS tissue plasminogen activator for acute ischemic stroke treatment trial
-
Ingall TJ, O'Fallon WM, Asplund K, Goldfrank LR, Hertzberg VS, Louis TA, et al. Findings from the reanalysis of the NINDS tissue plasminogen activator for acute ischemic stroke treatment trial. Stroke. 2004;35:2418-2424.
-
(2004)
Stroke.
, vol.35
, pp. 2418-2424
-
-
Ingall, T.J.1
O'Fallon, W.M.2
Asplund, K.3
Goldfrank, L.R.4
Hertzberg, V.S.5
Louis, T.A.6
-
16
-
-
84937711503
-
A critical review of stroke trial analytical methodology: Outcome measures, study design and correction for imbalances
-
Lapchak PA, Zhang JH, eds New York, NY: Springer
-
Mandava P, Krumpelman CS, Murthy SB, Kent TA. A critical review of stroke trial analytical methodology: outcome measures, study design and correction for imbalances. In: Lapchak PA, Zhang JH, eds. Translational Stroke Research: From Target Selection to Clinical Trials. New York, NY: Springer; 2012:833-862.
-
(2012)
Translational Stroke Research: From Target Selection to Clinical Trials
, pp. 833-862
-
-
Mandava, P.1
Krumpelman, C.S.2
Murthy, S.B.3
Kent, T.A.4
-
17
-
-
65549170306
-
A method to determine stroke trial success using multidimensional pooled control functions
-
Mandava P, Kent TA. A method to determine stroke trial success using multidimensional pooled control functions. Stroke. 2009;40: 1803-1810.
-
(2009)
Stroke.
, vol.40
, pp. 1803-1810
-
-
Mandava, P.1
Kent, T.A.2
-
18
-
-
77950292456
-
A matching algorithm to address imbalances in study populations: Application to the National Institute of Neurological Diseases and Stroke Recombinant Tissue Plasminogen Activator acute stroke trial
-
Mandava P, Kalkonde YV, Rochat RH, Kent TA. A matching algorithm to address imbalances in study populations: application to the National Institute of Neurological Diseases and Stroke Recombinant Tissue Plasminogen Activator acute stroke trial. Stroke. 2010;41:765-770.
-
(2010)
Stroke.
, vol.41
, pp. 765-770
-
-
Mandava, P.1
Kalkonde, Y.V.2
Rochat, R.H.3
Kent, T.A.4
-
19
-
-
77951622706
-
The central role of the propensity score in observational studies for causal effects
-
Rosenbaum PR, Rubin DB. The central role of the propensity score in observational studies for causal effects. Biometrika. 1983;70:41-55.
-
(1983)
Biometrika.
, vol.70
, pp. 41-55
-
-
Rosenbaum, P.R.1
Rubin, D.B.2
-
20
-
-
84871977989
-
Hemorrhagic transformation of ischemic stroke in diabetics on sulfo-nylureas
-
Kunte H, Busch MA, Trostdorf K, Vollnberg B, Harms L, Mehta RI, et al. Hemorrhagic transformation of ischemic stroke in diabetics on sulfo-nylureas. Ann Neurol. 2012;72:799-806.
-
(2012)
Ann Neurol.
, vol.72
, pp. 799-806
-
-
Kunte, H.1
Busch, M.A.2
Trostdorf, K.3
Vollnberg, B.4
Harms, L.5
Mehta, R.I.6
-
21
-
-
77954957785
-
A pilot trial of low-dose intravenous abciximab and unfractionated heparin for acute ischemic stroke: Translating GP IIb/IIIa receptor inhibition to clinical practice
-
Mandava P, Dalmeida W, Anderson JA, Thiagarajan P, Fabian RH, Weir RU, et al. A pilot trial of low-dose intravenous abciximab and unfractionated heparin for acute ischemic stroke: Translating GP IIb/IIIa receptor inhibition to clinical practice. Transl Stroke.Res. 2010;1:170-177.
-
(2010)
Transl Stroke.Res.
, vol.1
, pp. 170-177
-
-
Mandava, P.1
Dalmeida, W.2
Anderson, J.A.3
Thiagarajan, P.4
Fabian, R.H.5
Weir, R.U.6
-
22
-
-
44449108063
-
A user's guide to the NINDS rt-PA stroke trial database
-
Dachs RJ, Burton JH, Joslin J. A user's guide to the NINDS rt-PA stroke trial database. PLoS Med. 2008;5:e113.
-
(2008)
PLoS Med.
, vol.5
-
-
Dachs, R.J.1
Burton, J.H.2
Joslin, J.3
-
26
-
-
78650695325
-
Racial/ethnic disparities in emergency department waiting time for stroke patients in the United States
-
Karve SJ, Balkrishnan R, Mohammad YM, Levine DA. Racial/ethnic disparities in emergency department waiting time for stroke patients in the United States. J Stroke Cerebrovasc Dis. 2011;20:30-40.
-
(2011)
J Stroke Cerebrovasc Dis.
, vol.20
, pp. 30-40
-
-
Karve, S.J.1
Balkrishnan, R.2
Mohammad, Y.M.3
Levine, D.A.4
-
27
-
-
0035073903
-
Entry criteria and baseline characteristics predict outcome in acute stroke trials
-
Uchino K, Billheimer D, Cramer SC. Entry criteria and baseline characteristics predict outcome in acute stroke trials. Stroke. 2001;32: 909-916.
-
(2001)
Stroke.
, vol.32
, pp. 909-916
-
-
Uchino, K.1
Billheimer, D.2
Cramer, S.C.3
-
28
-
-
77952112006
-
ECASS, ATLANTIS, NINDS and EPITHET rt-PA Study Group. Time to treatment with intravenous alteplase and outcome in stroke: An updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials
-
Lees KR, Bluhmki E, von Kummer R, Brott TG, Toni D, Grotta JC, et al.; ECASS, ATLANTIS, NINDS and EPITHET rt-PA Study Group. Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials. Lancet. 2010;375:1695-1703.
-
(2010)
Lancet.
, vol.375
, pp. 1695-1703
-
-
Lees, K.R.1
Bluhmki, E.2
Von Kummer, R.3
Brott, T.G.4
Toni, D.5
Grotta, J.C.6
-
29
-
-
3242803609
-
Genotypes associated with myocardial infarction risk are more common in African Americans than in European Americans
-
Lanfear DE, Marsh S, Cresci S, Shannon WD, Spertus JA, McLeod HL. Genotypes associated with myocardial infarction risk are more common in African Americans than in European Americans. J Am Coll Cardiol. 2004;44:165-167.
-
(2004)
J Am Coll Cardiol.
, vol.44
, pp. 165-167
-
-
Lanfear, D.E.1
Marsh, S.2
Cresci, S.3
Shannon, W.D.4
Spertus, J.A.5
McLeod, H.L.6
-
30
-
-
38049069281
-
The relationship between cardiometabolic and hemostatic variables: Infuence of race
-
Perry A, Wang X, Goldberg R, Ross R, Jackson L. The relationship between cardiometabolic and hemostatic variables: infuence of race. Metabolism. 2008;57:200-206.
-
(2008)
Metabolism.
, vol.57
, pp. 200-206
-
-
Perry, A.1
Wang, X.2
Goldberg, R.3
Ross, R.4
Jackson, L.5
-
31
-
-
0035574670
-
Plasminogen activator inhibitor type 1 is increased in the arterial wall of type II diabetic subjects
-
Pandolf A, Cetrullo D, Polishuck R, Alberta MM, Calafore A, Pellegrini G, et al. Plasminogen activator inhibitor type 1 is increased in the arterial wall of type II diabetic subjects. Arterioscler Thromb Vasc Biol. 2001;21:1378-1382.
-
(2001)
Arterioscler Thromb Vasc Biol.
, vol.21
, pp. 1378-1382
-
-
Pandolf, A.1
Cetrullo, D.2
Polishuck, R.3
Alberta, M.M.4
Calafore, A.5
Pellegrini, G.6
-
32
-
-
68649088377
-
-
National Institute of Neurologic Diseases and Stroke; Accessed on February 11, 2012
-
O'Fallon WM, Asplund K, Goldfrank LR, Hertzberg VS, Ingall TJ, Louis TA. Report of the t-PA Review Committee. National Institute of Neurologic Diseases and Stroke; 2004. Available at: http://www.ninds. nih.gov/funding/review- committees/t-pa-review-committee/t-pa-com-mittee-report.pdf. Accessed on February 11, 2012.
-
(2004)
Report of the T-PA Review Committee
-
-
O'Fallon, W.M.1
Asplund, K.2
Goldfrank, L.R.3
Hertzberg, V.S.4
Ingall, T.J.5
Louis, T.A.6
-
33
-
-
2342468751
-
Points to consider on adjustment of baseline covariates
-
Committee for Proprietary Medicinal Products.
-
Committee for Proprietary Medicinal Products. Points to consider on adjustment of baseline covariates. Stat Med. 2004;23:701-709.
-
(2004)
Stat Med.
, vol.23
, pp. 701-709
-
-
-
34
-
-
0344299275
-
Baseline NIH Stroke Scale score strongly predicts outcome after stroke: A report of the Trial of Org 10172 in Acute Stroke Treatment (TOAST)
-
Adams HP Jr, Davis PH, Leira EC, Chang KC, Bendixen BH, Clarke WR, et al. Baseline NIH Stroke Scale score strongly predicts outcome after stroke: A report of the Trial of Org 10172 in Acute Stroke Treatment (TOAST). Neurology. 1999;53:126-131.
-
(1999)
Neurology.
, vol.53
, pp. 126-131
-
-
Adams, Jr.H.P.1
Davis, P.H.2
Leira, E.C.3
Chang, K.C.4
Bendixen, B.H.5
Clarke, W.R.6
-
35
-
-
79959970965
-
Racial-ethnic disparities in stroke care: The American experience: A statement for healthcare professionals from the American Heart Association/American Stroke Association
-
Cruz-Flores S, Rabinstein A, Biller J, Elkind MS, Griffth P, Gorelick PB, et al. Racial-ethnic disparities in stroke care: the American experience: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2011;42:2091-2116.
-
(2011)
Stroke.
, vol.42
, pp. 2091-2116
-
-
Cruz-Flores, S.1
Rabinstein, A.2
Biller, J.3
Elkind, M.S.4
Griffth, P.5
Gorelick, P.B.6
|